AIM Aim Immunotech Inc.

Fundamentals / CIK 0000946644 / USD

Aim Immunotech Inc. reported $91K in revenue and a net loss of $14.13M for the trailing twelve months ended September 30, 2026 (down 15.4% year over year), with a -12800.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AIM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$3.49M$1.74M$0-$27.12MFY 2016 Revenue: $92KFY 2016 Net Income: -$7.50M2016FY 2017 Revenue: $437KFY 2017 Net Income: -$8.26M2017FY 2018 Revenue: $367KFY 2018 Net Income: -$9.83M2018FY 2019 Revenue: $140KFY 2019 Net Income: -$9.40M2019FY 2020 Revenue: $163KFY 2020 Net Income: -$14.40M2020FY 2021 Revenue: $135KFY 2021 Net Income: -$19.13M2021FY 2022 Revenue: $141KFY 2022 Net Income: -$19.45M2022FY 2023 Revenue: $202KFY 2023 Net Income: -$28.96M2023FY 2024 Revenue: $170KFY 2024 Net Income: -$17.32M2024FY 2025 Revenue: $88KFY 2025 Net Income: -$13.96M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $88K $170K $202K $141K $135K $163K $140K $367K $437K $92K
Research & Development $3.92M $6.20M $10.94M $6.99M $7.67M $5.72M $4.65M $4.78M $4.10M $5.11M
Operating Income -$11.66M -$19.77M -$31.92M -$19.92M -$18.84M -$15.15M -$12.44M -$11.50M -$11.42M -$13.80M
EBITDA -$11.45M -$19.43M -$31.68M -$19.67M -$18.06M -$14.42M -$11.65M -$10.62M -$10.41M -$12.63M
Interest Expense $812K $585K -- -- $67K $672K $427K $201K $139K --
Income Before Tax -$13.96M -- -- -- -- -- -- -- -- --
Net Income -$13.96M -$17.32M -$28.96M -$19.45M -$19.13M -$14.40M -$9.40M -$9.83M -$8.26M -$7.50M
Basic EPS -$8.62 -$30.92 -$60.00 -$40.00 -$40.00 -$45.00 -$258.00 -$977.00 -$29.00 -$34.00
Diluted EPS -$8.62 -$30.92 -$60.00 -$40.00 -$40.00 -$45.00 -$258.00 -$977.00 -$29.00 -$34.00
Basic Shares Outstanding 1.6M 560.2K 485.9K -- 473.4K 318.4K 36.4K 10.0K 286.8K 218.2K
Diluted Shares Outstanding 1.6M 560.2K 485.9K 480.5K 473.4K 318.4K 36.4K 10.0K 286.8K 218.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $22K $26K $22K $21K $26K $25K $16K $45K
Research & Development $846K $589K $482K $1.06M $607K $1.17M $1.08M $1.66M
Operating Income -$2.96M -$3.51M -$2.23M -$2.95M -$2.45M -$2.65M -$3.62M -$5.86M
EBITDA -$2.91M -$3.47M -$2.18M -$2.91M -$2.39M -$2.59M -$3.56M -$5.78M
Interest Expense $259K $295K $304K -$42K $581K $149K $124K $132K
Net Income -$3.14M -$3.79M -$3.02M -$4.17M -$3.28M -$2.79M -$3.71M -$5.97M
Basic EPS -$0.21 -$0.43 -$0.69 -- -$1.57 -$3.68 -$0.05 --
Diluted EPS -$0.21 -$0.43 -$0.69 -- -$1.57 -$3.68 -$0.05 --
Basic Shares Outstanding 32.5M 17.1M 4.4M -- 2.1M 759.3K 703.3K --
Diluted Shares Outstanding 32.5M 17.1M 4.4M -- 2.1M 759.3K 703.3K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $2.98M $1.70M $5.44M $27.05M $32.09M $38.50M $1.47M $299K $1.41M $2.41M
Short-Term Investments $62K $2.28M $7.63M $7.14M $16.18M $15.88M $7.31M -- -- --
Cash & Short-Term Investments $3.05M $3.98M $13.07M $34.19M $48.27M $54.38M $8.78M $299K $1.41M $2.41M
Accounts Receivable, Net $7.0K -- $1.18M $1.68M -- $34K $44K $235K $24K --
Total Current Assets $3.29M $4.18M $14.56M $36.32M $50.21M $40.31M $10.45M $3.80M $3.50M $6.94M
Property, Plant & Equipment, Net $71K $108K $127K $195K $4.05M $6.47M $7.12M $7.78M $8.59M $9.51M
Intangible Assets $1.66M $2.59M $2.31M $1.94M $1.97M $1.50M $1.15M $911K $858K $872K
Long-Term Investments -- -- -- -- -- $15.38M -- -- -- --
Other Non-Current Assets $377K $1.11M $1.69M $1.20M $1.32M $748K $1.89M $1.35M $1.26M $1.55M
Total Non-Current Assets $2.49M $4.43M $4.83M $4.17M $7.49M $24.27M $10.31M $10.05M $10.70M $11.93M
Total Assets $5.78M $8.61M $19.38M $40.49M $57.70M $64.58M $20.75M $13.85M $14.21M $18.87M
Accounts Payable $1.63M $6.38M $6.44M $377K $198K $383K $472K $680K $741K $887K
Short-Term Debt $3.55M $2.31M -- -- -- $230K $214K $199K -- --
Total Current Liabilities $6.22M $9.54M $8.65M $1.36M $673K $1.10M $1.13M $5.29M $2.71M $2.44M
Long-Term Debt $927K $500K -- -- -- $1.88M $2.10M $2.32M -- --
Total Non-Current Liabilities $9.34M $395K $495K $659K $147K $2.19M $6.18M $2.97M $2.80M $940K
Total Liabilities $15.56M $9.93M $9.15M $2.02M $820K $3.29M $7.31M $8.27M $5.50M $3.38M
Total Debt (incl. Leases) $4.90M $3.44M $718K $837K $149K $2.29M $2.48M $2.52M -- --
Common Stock $3.0K $1.0K $49K $48K $48K $42K $10K $1.0K $33K $24K
Retained Earnings -$440.8M -$426.8M -$409.5M -$380.5M -$361.1M -$342.0M -$327.6M -$318.6M -$308.8M -$300.5M
Accumulated Other Comp. Income -- -- -- -- -- -$47K -- -- -- --
Total Stockholders' Equity -$9.78M -$1.32M $10.23M $38.47M $56.88M $61.29M $13.44M $5.58M $8.70M $15.50M
Total Equity -$9.78M -$1.32M $10.23M $38.47M $56.88M $61.29M $13.44M $5.58M $8.70M $15.50M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $6.89M $9.90M $5.82M $2.98M $2.35M $476K $898K $1.70M
Short-Term Investments $61K $64K $63K $62K $62K $359K $1.35M $2.28M
Cash & Short-Term Investments $6.95M $9.96M $5.88M $3.05M $2.41M $835K $2.25M $3.98M
Accounts Receivable, Net -- -- -- $7.0K -- -- -- --
Total Current Assets $7.34M $10.43M $6.21M $3.29M $2.58M $1.02M $2.58M $4.18M
Property, Plant & Equipment, Net $49K $54K $62K $71K $80K $89K $98K $108K
Intangible Assets $1.76M $1.71M $1.66M $1.66M $2.04M $2.17M $2.27M $2.59M
Other Non-Current Assets $407K $271K $327K $377K $362K $351K $745K $1.11M
Total Non-Current Assets $2.42M $2.30M $2.37M $2.49M $2.92M $3.10M $3.66M $4.43M
Total Assets $9.75M $12.73M $8.59M $5.78M $5.49M $4.13M $6.25M $8.61M
Accounts Payable $443K $480K $1.22M $1.63M $1.25M $7.30M $6.94M $6.38M
Short-Term Debt $1.44M $3.62M $4.00M $3.55M $1.88M $2.29M $1.95M $2.31M
Total Current Liabilities $2.67M $4.95M $6.14M $6.22M $4.04M $10.39M $9.77M $9.54M
Long-Term Debt $0 $0 $210K $927K -- $431K $436K $500K
Total Non-Current Liabilities $3.0K $41K $315K $9.34M $7.53M $282K $338K $395K
Total Liabilities $2.67M $4.99M $6.46M $15.56M $11.57M $10.68M $10.11M $9.93M
Total Debt (incl. Leases) $1.67M $3.92M $4.57M $4.90M $2.34M $3.24M $2.96M $3.44M
Common Stock $40K $29K $8.0K $3.0K $3.0K $1.0K $72K $1.0K
Retained Earnings -$450.7M -$447.6M -$443.8M -$440.8M -$436.6M -$433.3M -$430.5M -$426.8M
Total Stockholders' Equity $7.08M $7.74M $2.12M -$9.78M -$6.08M -$6.55M -$3.86M -$1.32M
Total Equity $7.08M $7.74M $2.12M -$9.78M -$6.08M -$6.55M -$3.86M -$1.32M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$13.96M -$17.32M -$28.96M -$19.45M -$19.13M -$14.40M -$9.40M -$9.83M -$8.26M -$7.50M
Depreciation & Amortization $210K $339K $238K $256K $775K $733K $792K $878K $1.00M $1.17M
Stock-Based Compensation $60K $686K $243K $954K $1.57M $1.04M $853K $929K $571K $52K
Change in Receivables -- $1.18M $492K -$35K $34K $40K -$191K -$1.07M -$24K --
Change in Payables -$1.71M -$60K $6.07M $179K -$185K -$89K -$207K $166K $566K -$326K
Operating Cash Flow -$10.96M -$14.89M -$21.27M -$16.11M -$13.96M -$10.37M -$9.07M -$10.64M -$7.94M -$7.38M
Capital Expenditure -- -$18K -- -$86K -$41K -$22K -$68K -$51K -$20K -$160K
Free Cash Flow -- -$14.91M -- -$16.19M -$14.01M -$10.39M -$9.13M -$10.69M -$7.96M -$7.54M
Purchases of Investments -$91K -$361K -$1.59M -$2.72M -$22.54M -$18.61M -$5.78M -- -- --
Investing Cash Flow $1.85M $4.71M -$832K $10.99M -$631K -$9.16M -$6.15M $92K $2.73M $2.92M
Common Stock Issued -- $892K $485K $80K $13.04M $61.25M $15.30M $5.07M $2.42M $4.74M
Financing Cash Flow $10.39M $6.44M $485K $80K $8.19M $56.56M $16.39M $9.44M $4.21M $4.76M
Net Change in Cash $1.28M -$3.74M -$21.61M -$5.04M -$6.41M $37.03M $1.17M -$1.11M -$996K $293K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$3.14M -$3.79M -$3.02M -$4.17M -$3.28M -$2.79M -$3.71M -$5.97M
Depreciation & Amortization $43K $44K $43K $43K $54K $55K $58K $79K
Stock-Based Compensation -- $0 $0 $0 $0 $0 $60K $196K
Change in Receivables -- -- -- -- -- -- -- $3.0K
Change in Payables -- -- -$415K -$56K -$2.57M $353K $561K $119K
Operating Cash Flow -$2.93M -$4.59M -$2.72M -$1.99M -$5.08M -$1.53M -$2.36M -$3.96M
Purchases of Investments $0 $0 -$6.0K $0 $0 $0 -$91K -$203K
Investing Cash Flow -$83K -$112K -$37K -$95K $296K $754K $898K $3.70M
Common Stock Issued $0 $537K $2.00M -- -$398K $105K $660K $32K
Financing Cash Flow $1.0K $8.79M $5.59M $2.72M $6.65M $355K $660K $1.04M
Net Change in Cash -$3.01M $4.08M $2.83M $638K $1.87M -$422K -$803K $786K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -13254.5% -11630.6% -15800.0% -14129.8% -13954.1% -9295.7% -8887.9% -3132.4% -2612.4% -15004.3%
Net Profit Margin -15861.4% -10188.2% -14337.6% -13790.8% -14168.1% -8834.4% -6717.1% -2677.7% -1889.9% -8154.3%
Return on Equity (ROE) -- -- -283.0% -50.5% -33.6% -23.5% -70.0% -176.1% -94.9% -48.4%
Return on Assets (ROA) -241.4% -201.2% -149.4% -48.0% -33.1% -22.3% -45.3% -71.0% -58.1% -39.7%
Current Ratio 0.53x 0.44x 1.68x 26.69x 74.61x 36.58x 9.27x 0.72x 1.29x 2.85x
Quick Ratio 0.49x 0.42x 1.65x 26.35x 71.72x 49.38x 7.83x 0.10x 0.53x 0.99x
Debt to Equity -- -- 0.07x 0.02x 0.00x 0.04x 0.18x 0.45x -- --
Revenue Growth (YoY) -48.2% -15.8% +43.3% +4.4% -17.2% +16.4% -61.9% -16.0% +375.0% -30.8%
5Y Revenue / Share Growth -89.4% -92.1% -98.9% -- -32.4% -24.3% +206.1% +40663.7% +908.9% +254.7%
10Y Revenue / Share Growth -92.0% -75.8% +363.8% -- +139.9% +408.2% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -12800.0% -11724.2% -10926.6% -13254.5% -13006.2% -13726.4% -12093.8% -11630.6%
Net Profit Margin -15526.4% -15021.1% -14123.4% -15861.4% -14062.5% -13360.3% -10416.4% -10188.2%
Return on Equity (ROE) -199.7% -184.3% -624.8% -- -- -- -- --
Return on Assets (ROA) -144.9% -112.1% -154.6% -241.4% -286.7% -391.5% -243.4% -201.2%
Current Ratio 2.75x 2.11x 1.01x 0.53x 0.64x 0.10x 0.26x 0.44x
Quick Ratio 2.60x 2.01x 0.96x 0.49x 0.60x 0.08x 0.23x 0.42x
Debt to Equity 0.24x 0.51x 2.15x -- -- -- -- --
Revenue Growth (YoY) -15.4% +4.0% +37.5% -53.3% -25.7% -50.0% -60.0% -30.8%
Source: SEC EDGAR CompanyFacts (CIK 0000946644) · from December 31, 2009 Data through September 30, 2026 · synced Nov 21, 2026, 05:09 UTC · Open in terminal